Exclusive

Publication

Byline

Merck expands M Lab collaboration center in Shanghai with additional Euro 14 M investment

Singapore, April 8 -- Merck, a leading science and technology company, has expanded its M Lab Collaboration Center in Shanghai, the company's largest in its global network of ten interconnected labs. ... Read More


New research partnership with UK to improve health in China's Greater Bay area

Singapore, April 8 -- Researchers at the University of Birmingham, UK and Seventh Affiliated Hospital of Sun Yat-sen University, China have joined forces to launch a joint clinical research institute ... Read More


Japanese firms Mitsui & Rohto Pharma buy Singapore-based consumer healthcare brand for Yen 88 B

Singapore, April 8 -- Japan-based Mitsui & Co., has decided to acquire shares in Eu Yan Sang International (EYS) jointly with Rohto Pharmaceutical and others. Based in Singapore, EYS manufactures and ... Read More


Australia's Starpharma and UK-based Medicxi create Petalion Therapeutics to develop novel dendrimer-based treatments

Singapore, April 8 -- Australia-based Starpharma has entered into a strategic partnership with UK headquartered Medicxi, a leading life sciences investment firm dedicated to financing companies develo... Read More


New South Wales government injects Dollar 5 M for critical research to address Silicosis crisis

Singapore, April 5 -- The New South Wales (NSW) government has committed Dollar 5 million in critical funding for silicosis research and a patient support programme for individuals and their families ... Read More


Singapore approves new asthma indication for GSK's Trelegy Ellipta

Singapore, April 5 -- GSK Singapore has announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilant... Read More


CMS and Incyte collaborate to develop vitiligo drug Povorcitinib in China and Southeast Asia

Singapore, April 4 -- China Medical System Holdings (CMS) and Incyte have entered into a collaboration and license agreement for the development and commercialisation of povorcitinib, a selective oral... Read More


Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases of Central Nervous System

Singapore, April 4 -- NS Pharma, Inc. has announced that its parent company, Nippon Shinyaku Co., headquartered in Kyoto, Japan, has entered into a joint research agreement with MiNA Therapeutics, hea... Read More


Driving Net Zero Healthcare in Asia and beyond

Singapore, April 3 -- In conversation with Professor Nick Watts, Director, Centre for Sustainable Medicine (CoSM), Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine). Pl... Read More


Singapore and Indonesia deepen cooperation in education with two new postgraduate scholarships

Singapore, April 3 -- Nanyang Technological University (NTU), Singapore and the Indonesia Endowment Fund for Education Agency (LPDP), a public service agency under Indonesia's Ministry of Finance, are... Read More